Monday, October 28, 2013 10:41:08 PM
Thanks for providing link to this Cardiogenics' WDM Capital presentation; slides 16 & 17 provide important information:
Slide 16 -
1.Confirmation that 200 patient Beta Site Study to be completed in Q4 2013
2.Informs FDA Pivotal Study will require only 200 additional patients
3.Informs/confirms that FDA Pivotal Study will be conducted at Wayne State hospitals
Slide 17 -
1.FDA 200 patient Pivotal Study targeted completion date of Mid-Q1 (February?)
2.510K submission to FDA targeted late Q3 2014 (August?)
3.Partnering discussions to complete end of Q1 2014 (Partner announcement April ?)
4.Q4 2014 Launch target date in United States
Ante
Recent CGNH News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/26/2024 04:25:43 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM